McDougall, C., McKay, G. A., & Fisher, M. Drugs for Diabetes: Part 6 GLP-1 Receptor Agonists. Br. J Cardiol. 2011;18(4):167-169.

McDougall, C., McKay, G. A., & Fisher, M. Drugs for Diabetes: Part 6 GLP-1 Receptor Agonists. Br. J Cardiol. 2011;18(4):167-169.

Garber, A. J. Long Acting Glucagon-Like Peptide 1 Receptor Agonists. Diabetes Care 2011 May; 34(Supplement 2): S279-S284. https://doi.org/10.2337/dc11-s231

Prasad-Reddy, L., and Isaacs, D. A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond. Drugs Context. 2015; 4: 212283. Published online 2015 Jul 9. doi: 10.7573/dic.212283

Cowan & Company. Therapeutic Categories Outlook: Diabetes/Obesity. Equity Research September 2016, p. 514-15.

McKee, S. (2016, December 6). Novo files once-weekly GLP-1 analogue semaglutide. Retrieved from http://www.pharmatimes.com/news/novo_files_once-weekly_glp-1_analogue_semaglutide_1180190

West Pharmaceutical Services Inc. published this content on 31 July 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 03 August 2017 14:40:09 UTC.

Original documenthttp://www.westpharma.com/en/blog/2017/July/growth-in-glp-1-drugs-may-offer-improved-outcomes-to-people-with-type-II-diabetes

Public permalinkhttp://www.publicnow.com/view/B0E0D5A5B986B3B943079ACF215D6F44F5424D02